A Double-blind, Placebo-controlled, Parallel-group, Flexible-dose Study of Venlafaxine Extended-release Capsules in Adult Outpatients With Panic Disorder.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Venlafaxine (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- 18 Aug 2009 Actual end date (Dec 2002) added as reported by ClinicalTrials.gov
- 18 Aug 2009 Actual initiation date (Apr 2001) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov